focus -WSS

focus

author：entertainment 2025-08-26 07:42:46 - browse：211

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Humana cuts profit projections as Medicare Advantage costs soar

WSS

Mitch McConnell episode has important public health takeaway

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Micronoma's microbiome cancer diagnostic approach under fire

5 important ways Henrietta Lacks changed medical science

The high personal cost of affirmative action for Black doctors

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Wikipedia

focus

Sign up for D.C. Diagnosis

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

NIH launches clinical trials and new research office for long Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why doctors need education on FDA device approval process

ChatGPT in medicine: STAT answers readers' burning questions

‘Oppenheimer’ and the risks of AI in health care

Bright Health sells Medicare Advantage business to Molina

AI generated plenty of interest at JPM but not a lot of trust

Medical records are filled with copy

Mitch McConnell episode has important public health takeaway

knowledge

Mitch McConnell episode has important public health takeaway

NIH director takes cautious approach to Biden drug pricing priority

Sage hopes for a blockbuster in antidepressant now before FDA

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Readout Newsletter: Merck, J&J, and long Covid

New brain studies show LSD's effects on the brain in full color

hotspot

Wikipedia

hotspot

Wikipedia